A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial
- DOI
- 10.1016/j.ygyno.2022.10.006
- Published
- 2022-12
- Container
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ygyno.2022.10.006,
title = {A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial},
author = {John H. Farley and William E. Brady and David O'Malley and Keiichi Fujiwara and Kan Yonemori and Albert Bonebrake and Angeles Alvarez Secord and Jean-Marie Stephan and Joan L. Walker and Joo-Hyun Nam and Michael J. Birrer and David M. Gershenson},
year = {2022},
journal = {Gynecologic Oncology},
doi = {10.1016/j.ygyno.2022.10.006},
url = {https://doi.org/10.1016/j.ygyno.2022.10.006}
}RIS
TY - JOUR TI - A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial AU - John H. Farley AU - William E. Brady AU - David O'Malley AU - Keiichi Fujiwara AU - Kan Yonemori AU - Albert Bonebrake AU - Angeles Alvarez Secord AU - Jean-Marie Stephan AU - Joan L. Walker AU - Joo-Hyun Nam AU - Michael J. Birrer AU - David M. Gershenson PY - 2022 JO - Gynecologic Oncology DO - 10.1016/j.ygyno.2022.10.006 UR - https://doi.org/10.1016/j.ygyno.2022.10.006 ER -
APA
Farley, J. H., Brady, W. E., O'Malley, D., Fujiwara, K., Yonemori, K., Bonebrake, A., Secord, A. A., Stephan, J., Walker, J. L., Nam, J., Birrer, M. J., & Gershenson, D. M. (2022). A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2022.10.006
Source records
- crossref · retrieved 2026-09-25T17:56:42.820Z